v2.4.0.8
Consolidated Statement of Income (USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income Statement [Abstract]      
Sales $ 44,033 $ 47,267 $ 48,047
Costs, Expenses and Other      
Materials and production 16,954 16,446 16,871
Marketing and administrative 11,911 12,776 13,733
Research and development 7,503 8,168 8,467
Restructuring costs 1,709 664 1,306
Equity income from affiliates (404) (642) (610)
Other (income) expense, net 815 1,116 946
Total Costs, Expenses and Other 38,488 38,528 40,713
Income Before Taxes 5,545 8,739 7,334
Taxes on Income 1,028 2,440 942
Net Income 4,517 6,299 6,392
Less: Net Income Attributable to Noncontrolling Interests 113 131 120
Net Income Attributable to Merck & Co., Inc. $ 4,404 $ 6,168 $ 6,272
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) $ 1.49 $ 2.03 $ 2.04
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) $ 1.47 $ 2.00 $ 2.02